Kübler N R
Klinik und Poliklinik für Mund-, Kiefer-, Gesichtschirurgie, Bayerische Julius-Maximilians-Universität Würzburg.
Mund Kiefer Gesichtschir. 1997 Feb;1(1):2-25. doi: 10.1007/BF03043502.
Traumata, diseases, developmental deformities, and tumor resections frequently cause bone defects and atrophies. In general, three different mechanisms exist by which bone restoration can be achieved: (1) osteogenesis initiated by vital, osteoblastic cells of autografts; (2) osteoconduction (or creeping substitution); and (3) osteoinduction. The latter mechanism means the differentiation of pluripotent, mesenchymal-type cells (located in a recipient bed with strong regenerative capacity) into cartilage- and bone-forming progenitor cells under the influence of inductive bone morphogenetic proteins (BMPs). Some BMPs are physiologically included in low concentrations as organic components in bone tissue. They can diffuse from demineralized bone implants into the recipient bed and induce a differentiation into new bone tissue. Nine different BMPs have been isolated, characterized, and cloned. Some of these possess inductive properties and can initiate new bone formation in muscle tissue or in bone defects. In the future recombinant BMPs will be available in unlimited quantities. This will lead to completely new therapeutic concepts in reconstructive bone surgery.
创伤、疾病、发育畸形及肿瘤切除常导致骨缺损和萎缩。一般来说,存在三种可实现骨修复的不同机制:(1)由自体移植物中有活力的成骨细胞启动的骨生成;(2)骨传导(或渐进性替代);(3)骨诱导。后一种机制是指多能间充质型细胞(位于具有强大再生能力的受体床中)在诱导性骨形态发生蛋白(BMP)的影响下分化为软骨和骨形成祖细胞。一些BMP作为有机成分以低浓度生理性地存在于骨组织中。它们可从脱矿骨植入物扩散到受体床并诱导分化为新的骨组织。已分离、鉴定并克隆出九种不同的BMP。其中一些具有诱导特性,可在肌肉组织或骨缺损中启动新骨形成。未来重组BMP将大量可得。这将导致重建骨外科出现全新的治疗理念。